Is apolipoprotein E epsilon 2 associated with new hemorrhage risk in brain arteriovenous malformations?
ApoE genotype may influence the risk of ICH in the natural course of brain AVM. The identification of genetic predictors of ICH risk may facilitate estimation of AVM natural history risk and individualize clinical decision-making and therapeutic recommendations.
The combination has a good palliative role as third-line chemotherapy in recurrent undifferentiated nasopharyngeal cancer.